Falcon Fund 2 Holding Company, L.P. 4
4 · MIMEDX GROUP, INC. · Filed Dec 27, 2023
Insider Transaction Report
Form 4
Falcon Fund 2 Holding Company, L.P.
10% Owner
Transactions
- Conversion
Series B Preferred Stock, par value $0.001 per share
2023-12-22−90,000→ 0 totalExercise: $3.85→ Common Stock (28,195,249 underlying) - Conversion
Common Stock, par value $0.001 per share
2023-12-22+28,195,249→ 28,195,249 total
Footnotes (1)
- [F1]On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share ("Series B Preferred Stock"), of MiMedx Group, Inc. (the "Issuer") held by Falcon Fund 2 Holding Company, L.P. (the "Reporting Person"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend.